Harmony Biosciences Holdings Inc (HRMY)

$32.04 0.62 (1.90%)

16:00 EDT HRMY Stock Quote Delayed 30 Minutes

7 Cheap Biotech Stocks With Major Upside Potential

By Josh Enomoto, InvestorPlace Contributor Jul 9, 2024

While the broader healthcare sector enjoys permanent relevance, you can potentially maximize your upside with cheap biotech stocks.

7 Undervalued Biotech Stocks to Buy for Big-Time Returns

7 Biotech Stocks to Buy on the Dip: June 2024

HRMY Stock Earnings: Harmony Biosciences Beats EPS, Misses Revenue for Q1 2024

Volume:

Previous Close -

Market Cap 1.82B

PE Ratio 13.87

EPS 2.31

Volume (Avg. Vol.) 325,917

Day's Range $31.89 - $32.79

52-Week Range $18.61 - $39.26

Dividend & Yield N/A (N/A)

HRMY Stock Predictions, Articles, and Harmony Biosciences Holdings Inc News

The 3 Most Undervalued Small-Cap Stocks to Buy in February 2024

By Gabriel Osorio-Mazzilli, InvestorPlace Contributor Feb 12, 2024

Small-cap stocks are the first ones to rally on a new business cycle, such as the business cycle starting recently.

The 3 Most Undervalued Russell 2000 Stocks to Buy in February 2024

By Josh Enomoto, InvestorPlace Contributor Feb 7, 2024

When it comes to undervalued Russell 2000 stocks, the narrative for targeting this specific space is the same as any other market-based motivation: buy low,…

7 Undervalued Biotech Stocks That are Flying Under the Clinical Radar

By Josh Enomoto, InvestorPlace Contributor Dec 17, 2023

With so many innovative firms skyrocketing this year, astute investors seeking compelling discounts may want to turn their attention to undervalued biotech picks. Just like…

Russell 2000 Front-Runners: 3 Stocks to Keep an Eye On

By Josh Enomoto, InvestorPlace Contributor Dec 7, 2023

While all eyes may be on the usual suspects of market hype and influence, astute investors with a contrarian streak may want to consider Russell…

Why Is Zynerba Pharmaceuticals (ZYNE) Stock Up 270% Today?

By Josh Enomoto, InvestorPlace Contributor Aug 14, 2023

With Harmony Biosciences acquiring Zynerba Pharmaceuticals, ZYNE stock jumped on both the buyout and the underlying therapeutic implications.

7 ‘Strong Buy’ Value Stocks You Should Be Loading Up On Now

By Josh Enomoto, InvestorPlace Contributor Aug 3, 2023

Although ultra-cheap ideas tend to carry significant risks, these strong buy value stocks offer the endorsement of analysts.

7 Best High-Growth Stocks to Buy if You’re a Young Investor

By Josh Enomoto, InvestorPlace Contributor Jun 29, 2023

If you’re just starting out and have plenty of time to work with, these are the high-growth stocks for young investors.

3 Biotech Stocks to Buy With Explosive Upside Potential

By Alex Sirois, InvestorPlace Contributor Jun 22, 2023

These three biotech stocks with high upside potential also display some significant risk, but less so than many of their small-cap peers.

7 Stocks to Buy to Bag Big-Time Returns in Q2

By Josh Enomoto, InvestorPlace Contributor Apr 16, 2023

If you’re willing to take huge risks, these stocks to buy might yield you massive gains in Q2 – or you could be looking at a tax write-off.

7 Biotech Stocks to Buy for 100% Returns

By Josh Enomoto, InvestorPlace Contributor Apr 9, 2023

If you can handle the risks associated with high volatility, these biotech stocks to buy might double the returns in your portfolio.

HRMY Stock Alert: Scorpion Short Report Sends Harmony Plunging

By Eddie Pan, InvestorPlace Financial News Writer Mar 28, 2023

Scorpion Capital has issued a short report on HRMY stock, alleging that the company's Wakix drug is not safe for the public.

7 Healthcare Stocks to Buy for Long-Term Growth and Stability

By Muslim Farooque, InvestorPlace Contributor Mar 21, 2023

These healthcare stocks to buy offer spectacular upside potential ahead in your defensive portfolio

The 7 Best Biotech Stocks to Buy for February 2023

By Josh Enomoto, InvestorPlace Contributor Feb 7, 2023

Following the wave of red ink last year, astute investors should target the best biotech stocks to buy this month for strong growth potential.

7 Healthcare Stocks That Will Be Big Winners in 2023

By Alex Sirois, InvestorPlace Contributor Jan 31, 2023

Healthcare stocks had a strong 2022 which will continue throughout 2023 making these picks ones to consider.

7 No-Brainer Biotech Stocks to Add to Your Buy List

By Josh Enomoto, InvestorPlace Contributor Jun 9, 2022

With the broader markets grumbling, investors should consider biotech stocks to buy for their permanently relevant profile.

3 Desirable Drug Stocks With Very Promising Pipelines

By Larry Ramer, InvestorPlace Contributor Feb 16, 2022

Drug makers with superb pipelines are likely to deliver great returns for long-term investors. Here are three drug stocks to consider.

Harmony Biosciences Holdings Inc (HRMY)

7 Cheap Biotech Stocks With Major Upside Potential

7 Undervalued Biotech Stocks to Buy for Big-Time Returns

7 Biotech Stocks to Buy on the Dip: June 2024

HRMY Stock Earnings: Harmony Biosciences Beats EPS, Misses Revenue for Q1 2024

Top 5 Stocks for 2024

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

Harmony Biosciences Holdings Inc (HRMY)

Top 5 Stocks for 2024

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

HRMY Stock Predictions, Articles, and Harmony Biosciences Holdings Inc News

Subscriber Sign in